TD Cowen lowered the firm’s price target on Novavax (NVAX) to $7 from $8 and keeps a Hold rating on the shares. The firm updated its model ahead ...
NASHVILLE, Tenn. (WSMV) - Since 2020, getting the Covid vaccine every fall has been a regular recommendation for most Americans, but that’s changing this year. The Food and Drug Administration (FDA) ...